CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas

MLA

Depei Li, et al. “CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.” Frontiers in Cell and Developmental Biology, vol. 9, Mar. 2021. EBSCOhost, https://doi.org/10.3389/fcell.2021.653240.

APA

Depei Li, Wanming Hu, Xiaoping Lin, Ji Zhang, Zhenqiang He, Sheng Zhong, Xia Wen, Peiyu Zhang, Xiaobing Jiang, Hao Duan, Chengcheng Guo, Jian Wang, Jing Zeng, Zhongping Chen, Yonggao Mou, & Ke Sai. (2021). CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.653240

Chicago

Depei Li, Wanming Hu, Xiaoping Lin, Ji Zhang, Zhenqiang He, Sheng Zhong, Xia Wen, et al. 2021. “CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.” Frontiers in Cell and Developmental Biology 9 (March). doi:10.3389/fcell.2021.653240.